Materials Today Bio, 2022 · DOI: https://doi.org/10.1016/j.mtbio.2022.100419 · Published: September 2, 2022
Bacterial infections pose significant challenges to human health. Nitric oxide (NO) is a broad-spectrum antimicrobial agent unaffected by bacterial resistance. S-nitrosoglutathione (GSNO), a donor of NO, is gaining attention for its antibacterial activity and biocompatibility. GSNO has several advantages as an endogenous RSNO. It is relatively stable, decomposes into biocompatible substances, and plays a critical role in inflammation and host defense. It also promotes angiogenesis. GSNO has become a hotspot for biomaterials in the last decade, such as hydrogels, polymers, films, nanoparticles, microspheres, implantable devices, and blood-contacting devices. GSNO enhances the antibacterial activity of medical devices and slows GSNO decomposition.
GSNO's broad-spectrum antibacterial activity and biocompatibility make it a promising agent for combating infections, especially those resistant to conventional antibiotics.
GSNO can be incorporated into various biomaterials (hydrogels, polymers, nanoparticles) to enhance their anti-infective properties and promote tissue regeneration.
GSNO-modified medical devices can reduce the risk of device-associated infections, improve hemocompatibility, and possess anti-thrombotic and anti-inflammatory properties.